Literature DB >> 20031577

Novel loci, including those related to Crohn disease, psoriasis, and inflammation, identified in a genome-wide association study of fibrinogen in 17 686 women: the Women's Genome Health Study.

Jacqueline S Danik1, Guillaume Paré, Daniel I Chasman, Robert Y L Zee, David J Kwiatkowski, Alex Parker, Joseph P Miletich, Paul M Ridker.   

Abstract

BACKGROUND: Fibrinogen is a multifunctional circulating glycoprotein involved in wound healing, thrombosis, platelet aggregation, and inflammation, and elevated levels predict vascular disease. Despite evidence of crucial biological function and moderate heritability, comprehensive analysis of the influence of genetic variation on fibrinogen is not available. METHODS AND
RESULTS: To address this issue, we undertook a genome-wide association study evaluating the potential relationships between 337 343 single-nucleotide polymorphisms (SNPs) and plasma fibrinogen levels among 17 686 apparently healthy women participating in the Women's Genome Health Study. As C-reactive protein is also an inflammatory marker known to predict cardiovascular diseases, we compared the determinants of fibrinogen levels with those of C-reactive protein. Four novel loci were identified, in addition to the fibrinogen gene cluster, which were associated with fibrinogen levels at genome-wide levels of significance (range of probability values from 8.82 x 10(-09) to 8.04 x 10(-39)). Two of the loci are related to common chronic inflammatory diseases: the first, at locus 5q31.1 (SLC22A5, SLC22A4, IRF1), lies immediately adjacent to a locus linked to Crohn disease (P value for lead SNP, 1.24 x 10(-12)) and the second, at locus 17q25.1 (CD300LF, SLC9A3R1, NAT9), has been associated with psoriasis (P value for lead SNP, 7.72 x 10(-11)). A third locus at 1q21.3 (IL6R) lies within the interleukin 6 receptor gene, a critical component of the inflammatory cascade (P value for lead SNP, 1.80 x 10(-11)). A novel locus at 2q34 (CPSI) participates in the urea cycle (P=8.82 x 10(-09)). The majority of implicated SNPs showed little evidence of dual association with C-reactive protein levels.
CONCLUSIONS: A genome-wide survey of the human genome identifies novel loci related to common chronic inflammatory diseases as genetic determinants of fibrinogen levels, in addition to loci that relate to the inflammatory cascade, the urea cycle, and the fibrinogen gene cluster.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20031577      PMCID: PMC2749513          DOI: 10.1161/CIRCGENETICS.108.825273

Source DB:  PubMed          Journal:  Circ Cardiovasc Genet        ISSN: 1942-3268


  33 in total

1.  Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease.

Authors:  J D Rioux; M J Daly; M S Silverberg; K Lindblad; H Steinhart; Z Cohen; T Delmonte; K Kocher; K Miller; S Guschwan; E J Kulbokas; S O'Leary; E Winchester; K Dewar; T Green; V Stone; C Chow; A Cohen; D Langelier; G Lapointe; D Gaudet; J Faith; N Branco; S B Bull; R S McLeod; A M Griffiths; A Bitton; G R Greenberg; E S Lander; K A Siminovitch; T J Hudson
Journal:  Nat Genet       Date:  2001-10       Impact factor: 38.330

2.  Estimation of levels of gene flow from DNA sequence data.

Authors:  R R Hudson; M Slatkin; W P Maddison
Journal:  Genetics       Date:  1992-10       Impact factor: 4.562

3.  Functional variants of OCTN cation transporter genes are associated with Crohn disease.

Authors:  Vanya D Peltekova; Richard F Wintle; Laurence A Rubin; Christopher I Amos; Qiqing Huang; Xiangjun Gu; Bill Newman; Mark Van Oene; David Cescon; Gordon Greenberg; Anne M Griffiths; Peter H St George-Hyslop; Katherine A Siminovitch
Journal:  Nat Genet       Date:  2004-04-11       Impact factor: 38.330

Review 4.  Acute-phase proteins and other systemic responses to inflammation.

Authors:  C Gabay; I Kushner
Journal:  N Engl J Med       Date:  1999-02-11       Impact factor: 91.245

5.  Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations.

Authors:  S E Humphries; M Cook; M Dubowitz; Y Stirling; T W Meade
Journal:  Lancet       Date:  1987-06-27       Impact factor: 79.321

6.  Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.

Authors:  John Danesh; Sarah Lewington; Simon G Thompson; Gordon D O Lowe; Rory Collins; J B Kostis; A C Wilson; A R Folsom; K Wu; M Benderly; U Goldbourt; J Willeit; S Kiechl; J W G Yarnell; P M Sweetnam; P C Elwood; M Cushman; B M Psaty; R P Tracy; A Tybjaerg-Hansen; F Haverkate; M P M de Maat; F G R Fowkes; A J Lee; F B Smith; V Salomaa; K Harald; R Rasi; E Vahtera; P Jousilahti; J Pekkanen; R D'Agostino; W B Kannel; P W F Wilson; G Tofler; C L Arocha-Piñango; A Rodriguez-Larralde; E Nagy; M Mijares; R Espinosa; E Rodriquez-Roa; E Ryder; M P Diez-Ewald; G Campos; V Fernandez; E Torres; R Marchioli; F Valagussa; A Rosengren; L Wilhelmsen; G Lappas; H Eriksson; P Cremer; D Nagel; J D Curb; B Rodriguez; K Yano; J T Salonen; K Nyyssönen; T-P Tuomainen; B Hedblad; P Lind; H Loewel; W Koenig; T W Meade; J A Cooper; B De Stavola; C Knottenbelt; G J Miller; J A Cooper; K A Bauer; R D Rosenberg; S Sato; A Kitamura; Y Naito; T Palosuo; P Ducimetiere; P Amouyel; D Arveiler; A E Evans; J Ferrieres; I Juhan-Vague; A Bingham; H Schulte; G Assmann; B Cantin; B Lamarche; J-P Després; G R Dagenais; H Tunstall-Pedoe; M Woodward; Y Ben-Shlomo; G Davey Smith; V Palmieri; J L Yeh; A Rudnicka; P Ridker; F Rodeghiero; A Tosetto; J Shepherd; I Ford; M Robertson; E Brunner; M Shipley; E J M Feskens; D Kromhout; A Dickinson; B Ireland; K Juzwishin; S Kaptoge; S Lewington; A Memon; N Sarwar; M Walker; J Wheeler; I White; A Wood
Journal:  JAMA       Date:  2005-10-12       Impact factor: 56.272

7.  Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q.

Authors:  J Tomfohrde; A Silverman; R Barnes; M A Fernandez-Vina; M Young; D Lory; L Morris; K D Wuepper; P Stastny; A Menter
Journal:  Science       Date:  1994-05-20       Impact factor: 47.728

8.  Circulating levels of interleukin-6, its soluble receptor and interleukin-6/interleukin-6 receptor complexes in patients with type 2 diabetes mellitus.

Authors:  S Kado; T Nagase; N Nagata
Journal:  Acta Diabetol       Date:  1999-06       Impact factor: 4.280

9.  Bcl I polymorphism in the fibrinogen beta-chain gene is associated with the risk of familial myocardial infarction by increasing plasma fibrinogen levels. A case-control study in a sample of GISSI-2 patients.

Authors:  F Zito; A Di Castelnuovo; C Amore; A D'Orazio; M B Donati; L Iacoviello
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-12       Impact factor: 8.311

10.  Common genetic variation in five thrombosis genes and relations to plasma hemostatic protein level and cardiovascular disease risk.

Authors:  Sekar Kathiresan; Qiong Yang; Martin G Larson; Amy L Camargo; Geoffrey H Tofler; Joel N Hirschhorn; Stacey B Gabriel; Christopher J O'Donnell
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-04-13       Impact factor: 8.311

View more
  42 in total

Review 1.  Genetics of atherothrombosis and thrombophilia.

Authors:  Anders Mälarstig; Anders Hamsten
Journal:  Curr Atheroscler Rep       Date:  2010-05       Impact factor: 5.113

2.  Association of genomic loci from a cardiovascular gene SNP array with fibrinogen levels in European Americans and African-Americans from six cohort studies: the Candidate Gene Association Resource (CARe).

Authors:  Christina L Wassel; Leslie A Lange; Brendan J Keating; Kira C Taylor; Andrew D Johnson; Cameron Palmer; Lindsey A Ho; Nicholas L Smith; Ethan M Lange; Yun Li; Qiong Yang; Joseph A Delaney; Weihong Tang; Geoffrey Tofler; Susan Redline; Herman A Taylor; James G Wilson; Russell P Tracy; David R Jacobs; Aaron R Folsom; David Green; Christopher J O'Donnell; Alexander P Reiner
Journal:  Blood       Date:  2010-10-26       Impact factor: 22.113

3.  Identification of cis-regulatory variation influencing protein abundance levels in human plasma.

Authors:  Anbarasu Lourdusamy; Stephan Newhouse; Katie Lunnon; Petra Proitsi; John Powell; Angela Hodges; Sally K Nelson; Alex Stewart; Stephen Williams; Iwona Kloszewska; Patrizia Mecocci; Hilkka Soininen; Magda Tsolaki; Bruno Vellas; Simon Lovestone; Richard Dobson
Journal:  Hum Mol Genet       Date:  2012-05-16       Impact factor: 6.150

4.  Integrated analysis of genomics, longitudinal metabolomics, and Alzheimer's risk factors among 1,111 cohort participants.

Authors:  Burcu F Darst; Qiongshi Lu; Sterling C Johnson; Corinne D Engelman
Journal:  Genet Epidemiol       Date:  2019-05-18       Impact factor: 2.135

5.  Genome-wide analyses identify common variants associated with macular telangiectasia type 2.

Authors:  Thomas S Scerri; Anna Quaglieri; Carolyn Cai; Jana Zernant; Nori Matsunami; Lisa Baird; Lea Scheppke; Roberto Bonelli; Lawrence A Yannuzzi; Martin Friedlander; Catherine A Egan; Marcus Fruttiger; Mark Leppert; Rando Allikmets; Melanie Bahlo
Journal:  Nat Genet       Date:  2017-02-27       Impact factor: 38.330

6.  Pleiotropic effects of HNF1A rs1183910 in a population-based study of 60,283 individuals.

Authors:  Kristine H Allin; Børge G Nordestgaard
Journal:  Diabetologia       Date:  2014-01-19       Impact factor: 10.122

Review 7.  The Genetic Architecture of Coronary Artery Disease: Current Knowledge and Future Opportunities.

Authors:  Jaana Hartiala; William S Schwartzman; Julian Gabbay; Anatole Ghazalpour; Brian J Bennett; Hooman Allayee
Journal:  Curr Atheroscler Rep       Date:  2017-02       Impact factor: 5.113

8.  Characterization, expression profile, polymorphism and association of porcine NAT9 gene.

Authors:  Zhao Jiugang; Lan Jing; Liu Yonggang
Journal:  Mol Biol Rep       Date:  2011-06-19       Impact factor: 2.316

9.  A genome-wide association study of the human metabolome in a community-based cohort.

Authors:  Eugene P Rhee; Jennifer E Ho; Ming-Huei Chen; Dongxiao Shen; Susan Cheng; Martin G Larson; Anahita Ghorbani; Xu Shi; Iiro T Helenius; Christopher J O'Donnell; Amanda L Souza; Amy Deik; Kerry A Pierce; Kevin Bullock; Geoffrey A Walford; Ramachandran S Vasan; Jose C Florez; Clary Clish; J-R Joanna Yeh; Thomas J Wang; Robert E Gerszten
Journal:  Cell Metab       Date:  2013-07-02       Impact factor: 27.287

10.  CD300f immunoreceptor is associated with major depressive disorder and decreased microglial metabolic fitness.

Authors:  Natalia Lago; Fernanda N Kaufmann; María Luciana Negro-Demontel; Daniela Alí-Ruiz; Gabriele Ghisleni; Natalia Rego; Andrea Arcas-García; Nathalia Vitureira; Karen Jansen; Luciano M Souza; Ricardo A Silva; Diogo R Lara; Bruno Pannunzio; Juan Andrés Abin-Carriquiry; Jesús Amo-Aparicio; Celia Martin-Otal; Hugo Naya; Dorian B McGavern; Joan Sayós; Rubèn López-Vales; Manuella P Kaster; Hugo Peluffo
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.